Investors

News & Press Releases

65 releases, newest first.

  1. Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer’s Disease Biomarkers

  2. Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

  3. Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

  4. Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease

  5. DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 Conference

  6. Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering

  7. As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives

  8. Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference

  9. DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR’s APOE Genotyping Test

  10. Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement